Head-to-head exploratory cohort of a Phase 3 trial showed first-in-class poze-cemdi combination treatment helped patients achieve and maintain greater disease…
Data from the ongoing Phase 1/2 ATALANTA-1 study in a heavily pretreated R/R NHL patient population demonstrate high antitumor activity…
ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP Pivotal…
Decision follows observations of liver transaminitis without clinically significant symptoms in some subjects on azelaprag Company will evaluate data from…
Dr. Airica Steed Honored as a Fellow in the American Academy of Nursing CLEVELAND, OH / ACCESSWIRE / December 6,…
The partnership improves individualized patient care by bringing integrated wellness and beauty solutions to the Richmond market. DALLAS, TX /…
DELRAY BEACH, Fla., Dec. 6, 2024 /PRNewswire/ -- The global Data Protection as a Service Market will grow to USD…
EAGAN, Minn., Dec. 6, 2024 /PRNewswire/ -- Smart Data Solutions (SDS), a leader in healthcare process automation and interoperability, announces…
New Study Reveals Current State and Future Expectations of Artificial Intelligence in Healthcare NEWARK, N.J., Dec. 6, 2024 /PRNewswire/ --…
HSINCHU, Dec. 6, 2024 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI), Taiwan's largest and one of the world's leading high-tech…